(ROOT (S (S (NP (@NP (NP (NNP NEW) (NNP YORK)) (: --)) (NP (@NP (NP (JJ Preliminary) (NN success)) (PP (IN with) (NP (NP (DT a) (NN variation)) (PP (IN of) (NP (DT an) (@NP (NN acne) (NN drug))))))) (S (VP (TO to) (VP (VB treat) (NP (DT an) (@NP (JJ adult) (NN leukemia)))))))) (VP (MD may) (VP (VB have) (VP (@VP (VBN opened) (NP (DT a) (@NP (JJ new) (NN avenue)))) (PP (TO to) (NP (NN attack) (NN cancer))))))) (@S (, ,) (@S (NP (NNS scientists)) (@S (VP (VBD said)) (. .))))))
(ROOT (S (S (SBAR (IN Although) (S (NP (PRP it)) (VP (@VP (@VP (VBZ is) (ADVP (RB still))) (ADJP (RB too) (JJ early))) (S (VP (TO to) (VP (VB gauge) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT the) (NN treatment)))))))))) (@S (, ,) (@S (NP (NP (CD 16)) (PP (IN of) (NP (NP (CD 20) (NNS patients)) (VP (@VP (VBN treated) (PRT (RP up))) (PP (TO to) (ADVP (NP (CD nine) (NNS months)) (RB ago))))))) (VP (VBP have) (VP (VBN been) (PP (IN in) (NP (NP (NN remission)) (PP (IN of) (NP (PRP$ their) (@NP (NN blood) (NN cancer))))))))))) (@S (, ,) (@S (NP (NP (NNS researchers)) (PP (IN from) (NP (NNP Memorial) (@NP (NNP Sloan-Kettering) (@NP (NNP Cancer) (NNP Center)))))) (@S (ADVP (RB here)) (@S (VP (VBD reported)) (. .)))))))
(ROOT (S (SBAR (IN Because) (S (PP (IN of) (NP (DT the) (NN way))) (@S (NP (DT the) (@NP (NN acne) (NN drug))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB work))))))))) (@S (, ,) (@S (NP (DT the) (NNS results)) (@S (VP (VBP support) (NP (NP (DT a) (@NP (JJ new) (NN concept))) (PP (IN of) (NP (NN cancer) (NN chemotherapy))))) (. .))))))
(ROOT (S (PP (IN In) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (NP (NN leukemia)) (VP (VBN suffered) (PP (IN by) (NP (DT the) (NNS patients)))))))) (@S (, ,) (@S (NP (JJ white) (@NP (NN blood) (NNS cells))) (@S (VP (VBP have) (VP (@VP (VBN turned) (ADJP (JJ malignant))) (PP (IN at) (NP (NP (DT an) (@NP (JJ immature) (NN stage))) (PP (IN of) (NP (NN cell) (NN development))))))) (. .))))))
(ROOT (S (NP (PRP$ Their) (@NP (VBN arrested) (NN development))) (@S (VP (VBZ is) (SBAR (WHNP (WP what)) (S (VP (VBZ renders) (S (NP (PRP them)) (ADJP (RB practically) (@ADJP (@ADJP (JJ immortal) (CC and)) (JJ dangerous)))))))) (. .))))
(ROOT (S (NP (DT The) (@NP (NN acne) (NN drug))) (@S (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (@VP (VB trigger) (NP (DT these) (@NP (ADJP (@ADJP (JJ immature) (CC but)) (JJ malignant)) (NNS cells)))) (S (VP (TO to) (VP (@VP (VP (@VP (VB divide) (CC and)) (VB mature)) (CC and)) (VP (ADVP (RB then)) (@VP (VB die) (NP (RB essentially) (@NP (DT a) (@NP (JJ natural) (NN death)))))))))))))) (. .))))
(ROOT (S (NP (NP (DT This) (@NP (JJ new) (NN concept))) (PP (IN of) (S (VP (@VP (VBG triggering) (NP (NN cancer) (NNS cells))) (S (VP (TO to) (VP (@VP (VB mature) (CC and)) (VB die)))))))) (@S (VP (VBZ contrasts) (PP (IN with) (NP (@NP (@NP (NP (DT the) (@NP (JJ conventional) (NN concept))) (PP (IN of) (NP (@NP (NP (NN chemotherapy)) (, ,)) (RRC (PP (IN in) (WHNP (WDT which))) (NP (NNS drugs)))))) (ADVP (RB simply))) (NP (NN poison) (@NP (JJ malignant) (NNS cells)))))) (. .))))
(ROOT (S (NP (NP (DT The) (NN drug)) (VP (VBN used) (PP (IN in) (NP (DT the) (@NP (JJ experimental) (NN treatment)))))) (@S (VP (VBZ is) (VP (VBN known) (PP (IN as) (NP (@NP (NP (NN tretinoin)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBZ belongs) (PP (TO to) (NP (NP (DT a) (NN class)) (PP (IN of) (NP (NP (NNS chemicals)) (VP (VBN called) (NP (NP (JJ retinoic) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ related) (PP (TO to) (NP (NP (NN vitamin) (NN A.)) (SBAR (S (NP (NNP Tretinoin)) (VP (VBZ is) (VP (@VP (VBN sold) (PP (IN in) (NP (NN ointment) (NN form)))) (PP (IN as) (NP (@NP (NP (NNP Retin-A)) (, ,)) (NP (NP (DT the) (@NP (NN acne) (NN medication))) (VP (VBN produced) (PP (IN by) (NP (NP (NNP Johnson) (@NP (CC &) (@NP (NNP Johnson) (POS 's)))) (@NP (NNP Ortho) (@NP (NNP Pharmaceutical) (NN division)))))))))))))))))))))))))))))))) (. .))))
(ROOT (S (NP (NP (DT The) (NN tretinoin)) (VP (VBN used) (PP (IN in) (NP (DT the) (@NP (NN leukemia) (NNS patients)))))) (@S (, ,) (@S (ADVP (RB however)) (@S (, ,) (@S (VP (VBZ is) (NP (NP (DT a) (NN pill)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (@VP (VBN prepared) (PP (IN for) (NP (DT the) (NN experiment)))) (PP (IN by) (NP (NP (NNS chemists)) (PP (IN at) (NP (@NP (NP (NNP Hoffmann-La) (@NP (NNP Roche) (NNP Inc.))) (, ,)) (NP (NP (DT the) (@NP (NNP U.S.) (NN arm))) (PP (IN of) (NP (NP (NNP Roche) (@NP (NNP Holding) (NNP Ltd.))) (PP (IN of) (NP (NNP Switzerland)))))))))))))))) (. .)))))))
(ROOT (S (NP (@NP (@NP (NP (NNP Roche)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (NP (DT a) (@NP (JJ long) (NN history))) (PP (IN of) (S (VP (VBG making) (NP (JJ retinoic) (NNS acids)))))))))) (, ,)) (@S (VP (@VP (@VP (@VP (VBZ sells) (NP (NP (CD one)) (PP (IN of) (NP (PRP$ its) (NNS acids))))) (PP (IN as) (NP (NNP Accutane)))) (, ,)) (NP (NP (DT a) (NN pill)) (PP (IN for) (S (VP (VBG treating) (NP (JJ severe) (NN acne))))))) (. .))))
(ROOT (S (NP (NP (DT The) (@NP (JJ particular) (NN form))) (PP (IN of) (NP (NP (NN leukemia)) (SBAR (WHNP (WDT that)) (S (VP (VBZ appears) (S (VP (TO to) (VP (@VP (VB respond) (ADVP (RB readily))) (PP (TO to) (NP (NP (DT the) (@NP (NN acne-drug) (NN type))) (PP (IN of) (NP (NN treatment)))))))))))))) (@S (VP (VBZ is) (VP (VBN called) (NP (ADJP (JJ acute) (JJ promyelocytic)) (NN leukemia)))) (. .))))
(ROOT (S (NP (PRP It)) (@S (VP (VBZ is) (NP (@NP (@NP (@NP (NP (DT an) (@NP (JJ uncommon) (NN cancer))) (, ,)) (VP (@VP (VBG afflicting) (PP (IN about) (NP (CD 1,000) (NNS Americans)))) (NP-TMP (DT a) (NN year)))) (, ,)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (JJ certain) (NNS cells)) (PP (IN in) (NP (DT the) (@NP (NN bone) (NN marrow))))) (VP (VBP become) (ADJP (JJ malignant) (SBAR (IN before) (S (NP (PRP they)) (VP (VBP have) (VP (VBN matured) (PP (IN into) (S (ADVP (RB fully)) (VP (VBG functioning) (NP (JJ white) (@NP (NN blood) (NNS cells)))))))))))))))) (. .))))
(ROOT (NP (@NP (NP (NP (DT The) (@NP (JJ malignant) (@NP (, ,) (@NP (JJ immature) (@NP (JJ white) (NNS cells)))))) (PRN (-LRB- -LRB-) (@PRN (VP (VBN known) (PP (IN as) (NP (NNS myelocytes)))) (-RRB- -RRB-)))) (NP (@NP (NP (NP (NN flood)) (NP (DT the) (@NP (NN blood) (NN stream)))) (, ,)) (NP (@NP (NP (VBG producing) (NN fatigue)) (, ,)) (NP (NN fever) (@NP (, ,) (@NP (NN weight) (@NP (@NP (NN loss) (CC and)) (NN bleeding)))))))) (. .)))
(ROOT (S (@S (@S (@S (S (PP (IN Until) (NP (RB now))) (@S (, ,) (@S (NP (NP (NN chemotherapy)) (PP (IN with) (NP (JJ standard) (@NP (JJ anti-cancer) (NNS drugs))))) (VP (VBZ has) (VP (VBN been) (NP (NP (DT the) (@NP (ADJP (RB only) (JJ effective)) (NN treatment))) (PP (IN for) (NP (JJ acute) (@NP (JJ promyelocyltic) (NN leukemia)))))))))) (, ,)) (CC but)) (S (NP (PRP it)) (VP (@VP (VBZ produces) (NP (NNS cures))) (PP (IN in) (PP (ADVP (RB only)) (@PP (IN about) (NP (NP (DT a) (JJ third)) (PP (IN of) (NP (NNS patients)))))))))) (. .)))
(ROOT (S (NP (NP (DT The) (NN tip-off)) (SBAR (IN that) (S (NP (DT an) (@NP (JJ tretinoin-like) (NN drug))) (VP (MD might) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG treating) (SBAR (S (NP (DT the) (NN leukemia)) (VP (@VP (VBD came) (PP (@PP (PP (IN from) (NP (@NP (@NP (@NP (NP (DT a) (@NP (JJ genetic) (NN finding))) (, ,)) (NP (NP (NNP Dr.) (@NP (NNP Raymond) (@NP (NNP P.) (@NP (NNP Warrell) (NNP Jr.))))) (PP (IN of) (NP (NNP Memorial) (NN Sloan-Kettering))))) (CC and)) (NP (NP (PRP$ his) (NNS colleagues)) (PP (IN in) (NP (NNP New) (NNP York)))))) (CC and)) (PP (IN at) (NP (NNP M.D.) (@NP (NNP Anderson) (@NP (NNP Cancer) (NNP Center))))))) (PP (IN in) (NP (NNP Houston))))))))))))))) (@S (VP (VBD reported) (PP (IN in) (NP (NP (NP (DT this) (@NP (NN week) (POS 's))) (@NP (NNP New) (@NP (NNP England) (NNP Journal)))) (PP (IN of) (NP (NNP Medicine)))))) (. .))))
(ROOT (S (NP (NP (JJS Most) (NNS patients)) (PP (IN with) (NP (JJ promyleocytic) (NN leukemia)))) (@S (ADVP (RB apparently)) (@S (VP (VBP have) (NP (@NP (NP (DT the) (@NP (JJ same) (NN defect))) (PP (IN in) (NP (CD two)))) (PP (IN of) (NP (@NP (NP (PRP$ their) (@NP (CD 23) (NNS chromosomes))) (, ,)) (NP (NP (DT the) (NNS structures)) (PP (IN in) (NP (NP (DT the) (NN cell)) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (NP (PDT all) (@NP (DT the) (NNS genes))))))))))))) (. .)))))
(ROOT (S (NP (NP (DT A) (NN piece)) (PP (IN of) (NP (NN chromosome) (@NP (NN number) (CD 17))))) (@S (VP (VBZ appears) (S (VP (TO to) (VP (@VP (VP (VB have) (VP (VBN broken) (S (ADJP (JJ loose))))) (CC and)) (VP (VB become) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (NN chromosome) (@NP (NN number) (CD 15)))))))))) (. .))))
(ROOT (S (NP-TMP (JJ Last) (NN year)) (@S (, ,) (@S (NP (JJ molecular) (NNS geneticists)) (@S (VP (VBD identified) (NP (@NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS genes)) (PP (IN in) (NP (NN chromosome) (CD 17)))))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN damaged) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN chunk)) (PP (IN of) (NP (DT the) (NN chromosome)))) (VP (VBD broke) (ADJP (JJ loose))))))))))) (. .))))))
(ROOT (S (NP (DT The) (@NP (VBN damaged) (NN gene))) (@S (PRN (, ,) (@PRN (S (NP (PRP it)) (VP (VBD turned) (PRT (RP out)))) (, ,))) (@S (VP (ADVP (RB ordinarily)) (@VP (VBD made) (NP (@NP (NP (DT a) (NN protein)) (PRN (: --) (@PRN (NP (DT a) (NN receptor)) (: --)))) (SBAR (WHNP (IN that)) (S (VP (VBD grabbed) (NP (NP (NN hold)) (PP (IN of) (NP (JJ retinoic) (NN acid)))))))))) (. .)))))
(ROOT (S (NP (@NP (NP (DT This)) (CC and)) (NP (JJ other) (@NP (NN laboratory) (NNS findings)))) (@S (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN immaturity)) (PP (IN of) (NP (DT the) (@NP (JJ leukemic) (@NP (JJ white) (@NP (NN blood) (NNS cells))))))) (VP (@VP (MD might) (ADVP (RB somehow))) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NP (DT a) (NN foul-up)) (PP (IN in) (NP (NP (DT the) (NN way)) (SBAR (S (NP (DT the) (NNS cells)) (VP (@VP (VP (VBD handled)) (CC or)) (VP (VBD failed) (S (VP (TO to) (VP (VB handle) (NP (JJ retinoic) (NN acid))))))))))))))))))) (. .))))
(ROOT (S (NP (NP (DT The) (NN nature)) (PP (IN of) (NP (DT the) (@NP (JJ genetic) (NN damage))))) (@S (ADVP (RB also)) (@S (VP (VBD hinted) (SBAR (IN that) (S (NP (NP (NNS doses)) (PP (IN of) (NP (JJ retinoic) (NNS acids)))) (VP (MD might) (VP (VB prod) (S (NP (DT the) (@NP (JJ immature) (@NP (JJ malignant) (NNS cells)))) (VP (TO to) (VP (@VP (VP (VB proceed) (PP (TO to) (NP (NN maturity)))) (CC and)) (VP (ADVP (RB then)) (@VP (VB die) (SBAR (IN as) (S (NP (JJ normal) (@NP (JJ white) (@NP (NN blood) (NNS cells)))) (VP (VBP do)))))))))))))) (. .)))))
(ROOT (S (`` ``) (@S (S (NP (PRP We)) (VP (@VP (VBP 're) (ADVP (RB now))) (NP (DT the) (@NP (JJ third) (@NP (NN group) (S (VP (TO to) (VP (@VP (VB show) (NP (@NP (@NP (NP (NNS remissions)) (-LRB- -LCB-)) (PP (IN with) (NP (NN tretinoin)))) (-RRB- -RCB-))) (PP (IN in) (NP (DT this) (NN leukemia))))))))))) (@S (, ,) (@S ('' '') (@S (S (VP (VBG following) (NP (JJ Chinese) (@NP (CC and) (@NP (JJ French) (NNS researchers)))))) (@S (, ,) (@S (NP (NNP Dr.) (NNP Warrell)) (@S (VP (VBD said)) (. .))))))))))
(ROOT (S (CC But) (@S (PRN (, ,) (@PRN (S (NP (PRP he)) (VP (VBD added))) (, ,))) (@S (NP (DT the) (@NP (NNP U.S.) (NN group))) (@S (VP (@VP (@VP (@VP (VBZ is) (NP (DT the) (@NP (JJ first) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (DT the) (NN drug)) (VP (VBZ works) (PP (IN by) (S (VP (@VP (VBG triggering) (NP (DT the) (@NP (JJ immature) (@NP (NN cancer) (NNS cells))))) (S (VP (@VP (@VP (VP (TO to) (VP (VB mature))) (, ,)) (CC or)) (VP (@VP (TO to) (`` ``)) (VP (VB differentiate))))))))))))))))) (, ,)) ('' '')) (PP (IN in) (NP (DT the) (@NP (NNS biologists) (NN jargon))))) (. .))))))
(ROOT (S (`` ``) (@S (S (NP (PRP We)) (VP (VBP 've) (VP (@VP (VBN documented) (ADVP (RB conclusively))) (SBAR (IN that) (S (NP (NP (NN differentiation)) (PP (IN as) (NP (NP (DT a) (NN method)) (PP (IN of) (NP (NP (NN cancer) (NN therapy)) (PP (IN in) (NP (NNS humans)))))))) (VP (VBZ is) (NP (DT a) (NN reality)))))))) (@S (, ,) (@S ('' '') (@S (NP (PRP he)) (@S (VP (VBD said)) (. .))))))))
